Truist Financial Lowers Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $975.00

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target reduced by equities research analysts at Truist Financial from $1,004.00 to $975.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. Truist Financial’s price target indicates a potential upside of 62.57% from […]